# Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes

> **NCT03363399** · — · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 60 (actual)

## Conditions studied

- Myelodysplastic Syndromes
- Chronic Myelomonocytic Leukemia

## Interventions

- **DIAGNOSTIC_TEST:** Flow cytometry analysis of neutrophil myeloperoxidase expression

## Key facts

- **NCT ID:** NCT03363399
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-22
- **Primary completion:** 2018-09-06
- **Final completion:** 2018-09-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03363399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03363399, "Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03363399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*